INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Thu, 15 May · 19:14 IST

Ind-Swift Laboratories Limited has informed the Exchange about Hearing of second motion petition and next date of hearing.

Nclt Scheme FiledStrategic Transactions View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories has informed the exchanges about the hearing of its Second Motion Petition before the NCLT Chandigarh Bench-II regarding the Scheme of Arrangement for the amalgamation of Ind-Swift Limited (Transferor Company) with Ind-Swift Laboratories Limited (Transferee Company). The hearing took place on 15th May 2025, where the Tribunal discussed the reports submitted by statutory authorities and considered further approval of the scheme. The next date of hearing has been fixed for 29th May 2025. This is a routine procedural update on the ongoing merger process between the two related entities.

Likely market impact

This is a progress update on the proposed amalgamation — no final NCLT approval has been granted yet, but the scheme is moving through the legal process. Shareholders should watch the next hearing on 29th May 2025 for any decisive ruling on the merger.